1. Home
  2.  |  
  3. Economy Current Affairs |  

CCEA approved two FIIs proposals in pharmaceutical companies Aurobindo and Glenmark

Apr 8, 2015 15:00 IST

he Union Cabinet Committee on Economic Affairs (CCEA) on 7 April 2015 approved two FIIs (Foreign Institutional Investors) proposals worth 4187 crore rupees in the pharmaceutical majors Aurobindo Pharma Ltd. and Glenmark Pharmaceutical Ltd.

The CCEA’s approval for QIBs (Qualified Institutional Buyers) in Aurobindo Pharma Ltd. will increase the FIIs share in the company from 27.32 to 34.32 resulting in an inflow of about 2165 crore rupees. The funds will enable the company to expand its operations in the areas of anti infective, cardiovascular and central nervous system related ingredients.

The CCEA’s clearance for FIIs in Glenmark Pharmaceutical Ltd. will increase the FIIs share in the company from 35.07 percent to 49 percent resulting in an inflow of about 2022 crore rupees.

 

Is this article important for exams ? Yes12 People Agreed

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK